Helicobacter pylori in Children and Adolescents: Increase of Primary Clarithromycin Resistance, 1997–2000
暂无分享,去创建一个
G. Amann | A. Hirschl | G. Granditsch | W. Huber | J. Crone | C. Binder | A. Innerhofer | Christa Binder
[1] P. Malfertheiner,et al. Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report , 2002, Alimentary pharmacology & therapeutics.
[2] F. Gottrand,et al. Helicobacter pylori in Children: Acquisition of Antimicrobial Resistance after an Initial Course of Treatment , 2001, Journal of Clinical Microbiology.
[3] H. Oh,et al. gyrA Mutations Associated with Quinolone Resistance in Bacteroides fragilis Group Strains , 2001, Antimicrobial Agents and Chemotherapy.
[4] C. Dupont,et al. Choosing triple therapy for Helicobacter pylori in children: antimicrobial resistance testing of first gastric biopsy culture may predict outcome. , 2001, Journal of pediatric gastroenterology and nutrition.
[5] C. Dupont,et al. High Levels of Resistance to Metronidazole and Clarithromycin in Helicobacter pylori Strains in Children , 2001, Journal of Clinical Microbiology.
[6] P. Apfalter,et al. In Vitro Activities of Linezolid Alone and in Combination with Amoxicillin, Clarithromycin, and Metronidazole againstHelicobacter pylori , 2000, Antimicrobial Agents and Chemotherapy.
[7] X. Shi,et al. Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin. , 2000, The Journal of antimicrobial chemotherapy.
[8] S. Koletzko,et al. helicobacter pylori Infection in Children: A Consensus Statement , 2000 .
[9] R. Spiller,et al. Antimicrobial Susceptibility Testing ofHelicobacter pylori in a Large Multicenter Trial: the MACH 2 Study , 1999, Antimicrobial Agents and Chemotherapy.
[10] D. Graham,et al. Antibiotic resistance in Helicobacter pylori : Implications for therapy , 1998 .
[11] F. Mégraud,et al. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. , 1998, Gastroenterology.
[12] S. Suerbaum,et al. Primary and Acquired Helicobacter pylori Resistance to Clarithromycin, Metronidazole, and Amoxicillin—Influence on Treatment Outcome , 1998, American Journal of Gastroenterology.
[13] Vergis En,et al. Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host. , 1997 .
[14] P Huovinen,et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.
[15] D. Graham,et al. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. , 1996, The American journal of gastroenterology.
[16] M. Nishio,et al. Budd-Chiari syndrome attributed to protein C deficiency. , 1996, The American journal of gastroenterology.
[17] J. Turnidge,et al. Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by triple therapy , 1996, Journal of gastroenterology and hepatology.
[18] J. Sloan,et al. Helicobacter pylori: comparison of DNA fingerprints provides evidence for intrafamilial infection. , 1993, Gut.
[19] P. Sherman,et al. Association of Campylobacter pylori on the gastric mucosa with antral gastritis in children. , 1987, The New England journal of medicine.
[20] B. Marshall,et al. UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS , 1983, The Lancet.
[21] J. Rosenblatt,et al. Antiparasitic agents. , 1999, Mayo Clinic proceedings.
[22] B. Drumm,et al. Clinical significance of Helicobacter infection in children. , 1998, British medical bulletin.
[23] V. Yu,et al. Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host. , 1997, Seminars in respiratory infections.
[24] H. Lamouliatte. [How to eradicate Helicobacter pylori?]. , 1994, Gastroentérologie Clinique et Biologique.